|
|
HOT TOPICS IN CARDIOLOGY: Issue 9, 2008
The treatment of hypertension and the prevention of organ damage
The treatment of hypertension and the prevention of organ damage
Antonio Coca, Cristina Sierra
Correspondence to:
Antonio Coca - MD, PhD, FRCP Professor of Medicine Department Head Hypertension Unit Department of Internal Medicine Institute of Medicine and Dermatology University of Barcelona Hospital Clinic Barcelona, Spain E-mail: acoca@clinic.ub.es
Summary
- AIM OF TREATMENT FOR HYPERTENSION
- CARDIOVASCULAR RISK STRATIFICATION TO DEFINE THERAPEUTIC ATTITUDES
- Contribution of blood pressure “per se” to the global absolute risk of patients
- Contribution of blood pressure in association with other cardiovascular risk factors to the global absolute risk of patients
- Contribution of blood pressure in association with multiple cardiovascular risk factors, metabolic syndrome, or subclinical organ damage to the global absolute risk of patients
- ANTIHYPERTENSIVE STRATEGIES TO ACHIEVE TARGET BLOOD PRESSURE DEPENDING ON GLOBAL RISK
- Blood pressure targets in patients at high or very high risk: hypertension in type 2 diabetics
- Blood pressure targets in elderly hypertensive patients
- Blood pressure targets in hypertensive patients with concomitant cerebrovascular disease
- Blood pressure targets in hypertensive patients with concomitant coronary heart disease or heart failure
- PREVENTION OF ORGAN DAMAGE IN ESSENTIAL HYPERTENSION
- HOW TO PROTECT THE KIDNEY IN HYPERTENSION
- Implications of microalbuminuria in hypertensive patients
- Antihypertensive therapy and microalbuminuria
- HOW TO PROTECT THE HEART IN HYPERTENSION
- Implications of left ventricular hypertrophy in hypertensive patients
- Antihypertensive therapy and left ventricular hypertrophy
- HOW TO PROTECT LARGE ARTERIES IN HYPERTENSION
- Implications of intima-media thickness in hypertensive patients
- Antihypertensive therapy and intima-media thickness
- HOW TO PROTECT THE BRAIN IN HYPERTENSION
- Antihypertensive therapy and cerebral WML
- Antihypertensive therapy and stroke
- Antihypertensive therapy and cognitive impairment
- DISEASE PREVENTION VERSUS EVENT PREVENTION: THE RELEVANCE OF INTERMEDIATE DISEASE MARKER ASSESSMENT
- THE MULTIFACTORIAL APPROACH IN HIGH RISK PATIENTS
- SUMMARY AND CONCLUSION
- REFERENCES
If you have a Username and Password, you may already access to this article. Please login below.
If you do not have a Username and Password, click the "Register" button below to purchase this article.
|
|